USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland and Labrador; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon
GrantRegions Object ( [regions] => Array ( ) [is_initialized] => [error_messages] => Array ( ) [qm] => QueryManager Object ( [is_debug] => [conn] => mysqli Object ( [affected_rows] => 9 [client_info] => mysqlnd 5.0.12-dev - 20150407 - $Id: 3591daad22de08524295e1bd073aceeff11e6579 $ [client_version] => 50012 [connect_errno] => 0 [connect_error] => [errno] => 0 [error] => [error_list] => Array ( ) [field_count] => 2 [host_info] => 172.16.38.157 via TCP/IP [info] => [insert_id] => 0 [server_info] => 5.5.5-10.5.18-MariaDB [server_version] => 100518 [stat] => Uptime: 3099339 Threads: 258 Questions: 529463443 Slow queries: 1306 Opens: 117572 Open tables: 2719 Queries per second avg: 170.831 [sqlstate] => 00000 [protocol_version] => 10 [thread_id] => 85924155 [warning_count] => 0 ) ) [has_regions] => 1 [state_names] => Array (  => Alabama;  => Alaska;  => Arizona;  => Arkansas;  => California;  => Colorado;  => Connecticut;  => Delaware;  => Florida;  => Georgia;  => Hawaii;  => Idaho;  => Illinois;  => Indiana;  => Iowa;  => Kansas;  => Kentucky;  => Louisiana;  => Maine;  => Maryland;  => Massachusetts;  => Michigan;  => Minnesota;  => Mississippi;  => Missouri;  => Montana;  => Nebraska;  => Nevada;  => New Hampshire;  => New Jersey;  => New Mexico;  => New York;  => North Carolina;  => North Dakota;  => New York City;  => Ohio;  => Oklahoma;  => Oregon;  => Pennsylvania;  => Rhode Island;  => South Carolina;  => South Dakota;  => Tennessee;  => Texas;  => Utah;  => Vermont;  => Virginia;  => Washington;  => Washington, DC;  => West Virginia;  => Wisconsin;  => Wyoming; ) [province_names] => Array (  => Alberta;  => British Columbia;  => Manitoba;  => New Brunswick;  => Newfoundland and Labrador;  => Northwest Territories;  => Nova Scotia;  => Nunavut;  => Ontario;  => Prince Edward Island;  => Quebec;  => Saskatchewan;  => Yukon; ) [country_names] => Array (  => American Samoa (USA)  => The Federated States of Micronesia (USA)  => Guam (USA)  => Marshall Islands (USA)  => Puerto Rico (USA)  => Republic of Palau (USA)  => Virgin Islands (USA)  => Northern Mariana Islands (USA) ) [is_israel] => 1 [territories] => Array (  => American Samoa (USA);  => Guam (USA);  => Puerto Rico (USA);  => Virgin Islands (USA);  => Northern Mariana Islands (USA); ) [free_associations] => Array (  => The Federated States of Micronesia (USA)  => Marshall Islands (USA)  => Republic of Palau (USA) ) )
International country outside of the USA, Israel and Canada.
Grants to USA, Canada, and International investigators for research studies focused on epilepsy. Interested applicants are required to submit a letter of intent prior to the full proposal. Funding is intended to support transformative projects by established and early-career researchers that address prevention, elimination, and disease modification.
The CURE Epilepsy Award reflects CURE Epilepsy’s continued focus on scientific advances that have the potential to truly transform the lives of those affected by epilepsy, with prevention and disease modification as critical goals. Key priority areas for the award include: 1) Basic mechanisms of epilepsy; 2) Acquired epilepsies; 3) Pediatric epilepsies; 4) SUDEP; 5) Treatment-resistant epilepsies; and 6) Sleep & epilepsy.
CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives:
Funding requests may include salary support for the Principal Investigator (PI), co-PIs, technical staff, supplies, animal costs, publication fees and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. Limited equipment purchases that are required to complete goals will be considered. See: https://www.cureepilepsy.org/wp-content/uploads/2021/11/2022-CURE-Epilepsy-Award-LOI-and-Full-Proposal-Guidelines_updated-092221.pdf#page=12
Estimated Size of Grant:
- Grants may be paid over 2 years.
- Anticipated Project Start Date: Fall 2023
- CURE Epilepsy does not provide deadline extensions.